Here, CXCL9 was significantly down-regulated in DPHCC tissues and not CK19+HCC tissues, and the immune microenvironment was suppressed, which may contribute to DPHCC having a worse prognosis than CK19+HCC. The gene discussed is CXCL9; the disease is hepatocellular carcinoma.